| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |